Found: 7
Select item for more details and to access through your institution.
Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers.
- Published in:
- Nature Communications, 2015, v. 6, n. 9, p. 8305, doi. 10.1038/ncomms9305
- By:
- Publication type:
- Article
MM-151 overcomes acquired resistance to cetuximab and panitumumab in colorectal cancers harboring EGFR extracellular domain mutations.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 324, p. 1, doi. 10.1126/scitranslmed.aad5640
- By:
- Publication type:
- Article
KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy.
- Published in:
- International Journal of Cancer, 2013, v. 133, n. 5, p. 1259, doi. 10.1002/ijc.28106
- By:
- Publication type:
- Article
Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer.
- Published in:
- Science Translational Medicine, 2014, v. 6, n. 224, p. 1, doi. 10.1126/scitranslmed.3007947
- By:
- Publication type:
- Article
Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer.
- Published in:
- Nature, 2012, v. 486, n. 7404, p. 532, doi. 10.1038/nature11156
- By:
- Publication type:
- Article
Combined RAF and MEK Inhibition to Treat Activated Non-V600 BRAF-Altered Advanced Cancers.
- Published in:
- Oncologist, 2024, v. 29, n. 1, p. 15, doi. 10.1093/oncolo/oyad247
- By:
- Publication type:
- Article
Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article